| |
| HRFTCA510
(Black top) |
 Celite® (diatomaceous
earth) activated, non-evacuated glass test tube. Features flip-top
for needleless blood sample transfer: Requires 2.0cc of fresh whole
blood. Barcode allows HEMOCHRON Response instruments to recognise
test. Recommended for monitoring heparin during cardiac surgery,
vascular surgery, PTCA, cardiac catheterization, extracorporeal circulation,
sheath pull, monitoring heparin drips, and post procedure monitoring. |
| |
| HRFTK-ACT
(Gold top) |
 Kaolin
activated, non-evacuated glass test tube. Features flip-top for needleless
blood sample transfer: Requires 2.0cc of fresh whole blood. Barcode
allows HEMOCHRON Response instruments to recognise test. Recommended
for monitoring heparin in the presence of low to moderate doses of
aprotinin during bypass surgery, and angioplasty. |
| |
| P214
(Clear top) |
 Glass-particulate
activated, non-evacuated plastic test tube. Features flip-top for
needleless blood sample transfer: Requires 0.4cc of whole blood.
Recommended for monitoring heparin during hemodialysis, hemofiltration,
and ECMO. |
| |
| RxDx® Anticoagulation
Management System |
| Every
day, medical professionals face the constant challenge of providing
safe, effective anticoagulation in cardiac bypass surgery. The RxDx
system provides a more standardised and predictable approach to hemostasis
management by assuring effective anticoagulation therapy. It offers
heparin and protamine monitoring assays both independent and linked
to injectable pharmaceuticals. In this way, both drug variability
and patient sensitivity are taken into consideration to more accurately
predict heparin and protamine doses. |
| |
| The
coagulation profile of a cardiac patient may be further complicated
by previous exposure to heparin and treatment with thrombolytic agents
or nitroglycerin. With the RxDx system, heparin resistant and heparin
sensitive patients are dosed according to their individual dose response
rather than simply their weight, resulting in lower protamine doses,
less post-operative blood loss, and reduced administration of transfusion
products. |
| |
| RxDx® Heparin
Response Test |
For
bypass surgery and aggressive cardiac invasive procedures. Contains
heparin and either diatomaceous earth (Celite) or kaolin activator.
The Celite HRT is used in conjunction with the Celite ACT. The Kaolin
HRT is used in conjunction with the kaolin ACT. Celite system is
available matched to HEMOCHRON heparin (U.S.ONLY).
Clinical
applications for HRT include: determining the bolus heparin dose during
cardiac bypass surgery. |
| |
| R-HRT480P
(Mint Green top) |
 Porcine
heparin with Celite activator. |
| |
| R-HRT480PK
(Mint Green top) |
 Porcine
heparin with Kaolin activator. |
| |
| Protamine
Response Test |
For
bypass surgery when specified levels of heparin are present. Contains
protamine and either diatomaceous earth (Celite) or kaolin activator.
The Celite PRT is used in conjunction with the Celite ACT. The Kaolin
PRT is used in conjunction with the kaolin ACT. Celite system is
available matched to HEMOCHRON protamine (U.S.ONLY).
Clinical applications for the PRT include:
determining the protamine dose required to reverse the effects
of heparin given during cardiac bypass surgery. |
| |
| R-PRT200
(Peach top) |
 Protamine
with Celite activator. For use with low to moderate heparin levels. |
| |
| R-PRT200K
(Peach top) |
 Protamine
with kaolin activator. For use with moderate to high heparin levels. |
| |
| R-PRT400
(Red top) |
 Protamine
with Celite activator. For use with low to moderate heparin levels. |
| |
| R-PRT400K
(Red top) |
 Protamine
with kaolin activator. For use with moderate to high heparin levels. |
| |
| Protamine
Dose Assay (PDAO) |
Verifies
complete heparin neutralisation following protamine administration
at the close of cardiac bypass surgery. Can be used to calculate
the subsequent protamine dose required to neutralise any residual
heparin. Used in conjunction with a Celite ACT. Contains protamine
sulphate and diatomaceous earth.
Clinical applications for the PDAO include:
quantifying of additional protamine requirements at the conclusion
of cardiac bypass surgery. |
| |
| PDAO
(Orange top) |
 Protamine
with Celite activator. For detection of trace amounts of on-board
heparin. |
